EC Microbiology

While the know-how regarding the medical diagnosis as well as procedure of osteoporosis has grown greatly over a final couple of years, gaps in know-how still exist along with guidance being without the necessary monitoring of many common professional situ- ations like when to start drug therapy in a patient along with reduced bone tissue thickness. It is predicted that 34 thousand people in United States have low bone quality and are at a greater risk for low risk fractures. In this review, we will discuss osteoporosis analysis, typical reasons for therapy failure, as well as the strategy to the patients who are not responding to necessary treatment.

Aim: In this review, we will discuss osteoporosis along its management in general practice.

Keywords: Osteoporosis; Family Practice; Management; BMD

1. Sozen T., et al. “An overview and management of osteoporosis”. European Journal of Rheumatology 4 (2017): 46-56.
2. Schousboe JT., et al. “Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry”. Journal of Clinical Densitometry 16 (2013): 455-466.
3. Compston., et al. “Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013”. Maturitas 75 (2013): 392-396.
4. Kanis JA., et al. “A meta-analysis of previous fracture and subsequent fracture risk”. Bone 35 (2004): 375-382.
5. Panel on Prevention of Falls in Older Persons AGS, British Geriatrics S. Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. Journal of the American Geriatrics Society 59 (2011): 148-157.
6. Gluszko P., et al. “Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update”. Polish Archives of Internal Medicine 124 (2014): 255-263.
7. Cosman F., et al. “Clinician’s Guide to Prevention and Treatment of Osteoporosis”. Osteoporosis International 25 (2014): 2359-2381.
8. Kanis JA., et al. “European guidance for the diagnosis and management of osteoporosis in postmenopausal women”. Osteoporosis International 30 (2019): 3-44.
9. Eastell R., et al. “Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients”. Osteoporosis International 11 (2000): 331-337.
10. Reid DM., et al. “Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial”. Lancet 373 (2009): 1253-1263.
11. Jaglal SB., et al. “How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs”. Canadian Family Physician 49 (2003): 462-468.
12. Solomon DH., et al. “Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment”. The Journal of Rheumatology 27 (2000): 1496-1500.
13. Reploh H and Nehrkorn A. “Experience with oxidation trenches, a contribution on the sanitation of dairy wastes”. Arch for Hygiene und Bakteriologie 150 (1966): 237-248